Risk factors for failing to complete gemcitabine-cisplatin neoadjuvant chemotherapy in muscle invasive bladder cancer patients.
Homin KangJungyo SuhDalsan YouIn Gab JeongBumsik HongJun Hyuk HongHanjong AhnBumjin LimPublished in: Investigative and clinical urology (2024)
Thus, older age and presence of DM are potential risk factors for GP NAC discontinuation in patients with MIBC. Further studies are required to validate our findings and develop strategies to minimize the rate of GP NAC discontinuation in this population.
Keyphrases
- neoadjuvant chemotherapy
- locally advanced
- muscle invasive bladder cancer
- end stage renal disease
- transcription factor
- ejection fraction
- newly diagnosed
- chronic kidney disease
- lymph node
- peritoneal dialysis
- sentinel lymph node
- squamous cell carcinoma
- prognostic factors
- physical activity
- rectal cancer
- skeletal muscle
- middle aged
- early stage
- patient reported outcomes
- patient reported
- insulin resistance
- weight loss
- community dwelling